Quantcast
Channel: PRESSEMITTEILUNGEN » Cnsx
Browsing latest articles
Browse All 12 View Live

Biosign Signs Master Distribution Agreement With DLF Solutions Inc. for...

Toronto, April 16, 2010 (ots/PRNewswire) – Biosign Technologies Inc. (CNSX: BIO) (“Biosign” or the “Company”), and DLF Solutions Inc. (DLF), today announced they have signed a binding Heads of...

View Article



Biosign Signs European Distribution Agreement

Toronto, July 2, 2010 (ots/PRNewswire) – Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the...

View Article

Colt wird an der OTCQX gelistet

Montreal (ots/PRNewswire) – Börsenkürzel: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK – (USA Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) freut sich, bekanntgeben zu können, dass Colt...

View Article

Colt Resources Inc. schlägt Verlängerung und Abänderung von Optionsscheinen vor

Montreal (ots/PRNewswire) – Börsenkürzel: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK – (USA OTC Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) schlägt vor, 3.908.000 Optionsscheine, die...

View Article

Colt ernennt neuen Direktor: Declan Costelloe

Montreal (ots/PRNewswire) – Handelskennzeichen: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK (US OTC Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) ist erfreut darüber bekannt geben zu...

View Article


Colt fährt mit einer Privatplatzierung fort

Montreal (ots/PRNewswire) – Kennzeichen: GTP – (CNSX) P01 – (FRANKFURT) COLTF – (OTCQX) Colt Resources Inc. (“Colt” oder das “Unternehmen”) fährt mit einer nicht durch einen Broker vermittelten...

View Article

Pivotal Announces Scientific Presentation at the 17th World Congress on Heart...

Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on cardiovascular health, is pleased to announce that data...

View Article

Pivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012

Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to...

View Article


Pivotal Therapeutics Inc. Generates Positive Feedback at European Society of...

Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to...

View Article


Pivotal’s Founder and Chairman Dr. George Jackowski receives Queen Elizabeth...

Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and...

View Article

Pivotal Therapeutics VASCAZEN®-REVEAL Trial Meets Primary and Secondary...

Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and...

View Article

Hybrid Paytech Chooses Vodafone to Securely Connect its Pioneering Global...

Montreal (ots/PRNewswire) – World’s first service to securely process both debit and credit card transactions anywhere using standard mobile devices connected to card readers Hybrid PayTech, a division...

View Article
Browsing latest articles
Browse All 12 View Live




Latest Images